200 related articles for article (PubMed ID: 1687463)
1. Cyclic somatostatin analogues as potent antagonists at mu-, but not delta- and kappa-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the brain.
Mulder AH; Wardeh G; Hogenboom F; Kazmierski W; Hruby VJ; Schoffelmeer AN
Eur J Pharmacol; 1991 Nov; 205(1):1-6. PubMed ID: 1687463
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptors.
Kazmierski W; Wire WS; Lui GK; Knapp RJ; Shook JE; Burks TF; Yamamura HI; Hruby VJ
J Med Chem; 1988 Nov; 31(11):2170-7. PubMed ID: 2903246
[TBL] [Abstract][Full Text] [Related]
3. Antagonist activity of the cyclic somatostatin analogue CTP at mu- but not delta- and kappa-opioid receptors involved in presynaptic inhibition of neurotransmitter release.
Mulder AH; Wardeh G; Kazmierski W; Hruby VJ
Eur J Pharmacol; 1988 Nov; 157(1):109-14. PubMed ID: 2906879
[TBL] [Abstract][Full Text] [Related]
4. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
Chieng B; Connor M; Christie MJ
Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.
Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL
Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074
[TBL] [Abstract][Full Text] [Related]
6. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate.
Schoffelmeer AN; Rice KC; Jacobson AE; Van Gelderen JG; Hogenboom F; Heijna MH; Mulder AH
Eur J Pharmacol; 1988 Sep; 154(2):169-78. PubMed ID: 2906610
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors.
Pelton JT; Kazmierski W; Gulya K; Yamamura HI; Hruby VJ
J Med Chem; 1986 Nov; 29(11):2370-5. PubMed ID: 2878079
[TBL] [Abstract][Full Text] [Related]
8. Selective effects of [D-Ser2(O-t-butyl),Leu5]enkephalyl-Thr6 and [D-Ser2(O-t-butyl),Leu5]enkephalyl-Thr6 (O-t-butyl), two new enkephalin analogues, on neurotransmitter release and adenylate cyclase in rat brain slices.
De Vries TJ; Schoffelmeer AN; Delay-Goyet P; Roques BP; Mulder AH
Eur J Pharmacol; 1989 Nov; 170(3):137-43. PubMed ID: 2575993
[TBL] [Abstract][Full Text] [Related]
9. Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
Schoffelmeer AN; De Vries TJ; Hogenboom F; Hruby VJ; Portoghese PS; Mulder AH
J Pharmacol Exp Ther; 1992 Oct; 263(1):20-4. PubMed ID: 1328606
[TBL] [Abstract][Full Text] [Related]
10. Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo.
Kramer TH; Shook JE; Kazmierski W; Ayres EA; Wire WS; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 May; 249(2):544-51. PubMed ID: 2566679
[TBL] [Abstract][Full Text] [Related]
11. Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action.
Horan PJ; Wild KD; Kazmierski WM; Ferguson R; Hruby VJ; Weber SJ; Davis TP; Fang L; Knapp RJ; Yamamura HI
Eur J Pharmacol; 1993 Mar; 233(1):53-62. PubMed ID: 8386089
[TBL] [Abstract][Full Text] [Related]
12. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
13. Selectivity of various opioid peptides towards delta-, kappa; and mu-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the brain.
Mulder AH; Wardeh G; Hogenboom F; Frankhuyzen AL
Neuropeptides; 1989; 14(2):99-104. PubMed ID: 2573000
[TBL] [Abstract][Full Text] [Related]
14. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
Hawkins KN; Knapp RJ; Lui GK; Gulya K; Kazmierski W; Wan YP; Pelton JT; Hruby VJ; Yamamura HI
J Pharmacol Exp Ther; 1989 Jan; 248(1):73-80. PubMed ID: 2563293
[TBL] [Abstract][Full Text] [Related]
15. Beta-endorphin: a highly selective endogenous opioid agonist for presynaptic mu opioid receptors.
Schoffelmeer AN; Warden G; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1991 Jul; 258(1):237-42. PubMed ID: 1677039
[TBL] [Abstract][Full Text] [Related]
16. H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2: a potent and selective antagonist opioid receptors.
Gulya K; Lui GK; Pelton JT; Kazmierski W; Hruby VJ; Yamamura HI
NIDA Res Monogr; 1986; 75():209-12. PubMed ID: 2893264
[TBL] [Abstract][Full Text] [Related]
17. Opioid actions on neurons of rat lateral amygdala in vitro.
Sugita S; North RA
Brain Res; 1993 May; 612(1-2):151-5. PubMed ID: 8101129
[TBL] [Abstract][Full Text] [Related]
18. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of norepinephrine release from rat cortex slices by opioids: differences among agonists in sensitivities to antagonists suggest receptor heterogeneity.
Kim KW; Cox BM
J Pharmacol Exp Ther; 1993 Dec; 267(3):1153-60. PubMed ID: 8263776
[TBL] [Abstract][Full Text] [Related]
20. Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain.
De Vries TJ; Hogenboom F; Mulder AH; Schoffelmeer AN
Brain Res Dev Brain Res; 1990 Jun; 54(1):63-9. PubMed ID: 2163782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
